Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
- Resource Type
- Article
- Source
- The Lancet; March 2024, Vol. 403 Issue: 10432 p1153-1163, 11p
- Subject
- Language
- ISSN
- 01406736; 1474547X